.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Griseofulvin, ultramicrosize - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for griseofulvin, ultramicrosize?

Griseofulvin, ultramicrosize is the generic ingredient in three branded drugs marketed by Sigmapharm Labs Llc, Riconpharma Llc, and Valeant Pharms Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, ultramicrosize. Six suppliers are listed for this compound.

Summary for Generic Name: griseofulvin, ultramicrosize

Tradenames:3
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list50
Clinical Trials: see list5
Patent Applications: see list5,880
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:griseofulvin, ultramicrosize at DailyMed

Pharmacology for Ingredient: griseofulvin, ultramicrosize

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Riconpharma Llc
GRISEOFULVIN, ULTRAMICROSIZE
griseofulvin, ultramicrosize
TABLET;ORAL204371-002Jan 9, 2014RXNoNo► Subscribe► Subscribe
Riconpharma Llc
GRISEOFULVIN, ULTRAMICROSIZE
griseofulvin, ultramicrosize
TABLET;ORAL204371-001Jan 9, 2014RXNoNo► Subscribe► Subscribe
Sigmapharm Labs Llc
GRISEOFULVIN,ULTRAMICROSIZE
griseofulvin, ultramicrosize
TABLET;ORAL202545-001Oct 22, 2012RXNoNo► Subscribe► Subscribe
Valeant Pharms Inc
GRIS-PEG
griseofulvin, ultramicrosize
TABLET;ORAL050475-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Valeant Pharms Inc
GRIS-PEG
griseofulvin, ultramicrosize
TABLET;ORAL050475-001Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc